Quinoa (Chenopodium quinoa Willd.): Exploring a Superfood from Andean Indigenous Cultures with Potential to Reduce Cardiovascular Disease (CVD) Risk Markers.
Curr Mol Pharmacol
; 14(6): 925-934, 2021.
Article
en En
| MEDLINE
| ID: mdl-33430757
ABSTRACT
BACKGROUND:
The pseudo-cereal quinoa has attracted worldwide attention in recent years, due to it being considered a functional food. This stress-tolerant crop has historically been used by Andean cultures as a staple food. Nowadays, the consumption of quinoa in high-income countries is increasing due to it being associated with numerous health benefits, namely related to cardiovascular health.OBJECTIVE:
We have carried out an extensive review on quinoa, including its main uses, applications, and components (nutrients, antinutrients, and bioactives) and their relationship with biological activities and cardiovascular health. Key findings andConclusions:
Quinoa possesses numerous activities, including protection against cardiovascular, metabolic, and degenerative diseases, improvement of the immune system, reduction of symptoms associated with post-menopause, and promotion of muscle mass increase. Some of the quinoa's activities are due to its balanced amino acid profile, high fiber content, presence of phosphorus, iron, potassium, magnesium, vitamin E, and B vitamins. A plethora of bioactives can also be found in quinoa, such as phytosterols, saponins, phenolics, bioactive peptides, and phytoecdysteroids. More research is needed to better understand the mechanisms of action involved in the biological/therapeutic action of some quinoa components, namely those related to the potential to reduce cardiovascular disease (CVD) risk markers. The knowledge of factors that affect quinoa variability, such as processing conditions, is also of great importance for being able to obtain more benefits from this crop.Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Enfermedades Cardiovasculares
/
Chenopodium quinoa
Tipo de estudio:
Etiology_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Curr Mol Pharmacol
Asunto de la revista:
FARMACOLOGIA
Año:
2021
Tipo del documento:
Article
País de afiliación:
México